Characteristic | Before matching | p-value | After matching | p-value | ||
---|---|---|---|---|---|---|
PA n = 57 | Non-PA | PA | Non-PA | |||
n = 221 | n = 57 | n = 57 | ||||
Gender (n) | Â | Â | 0.299 | Â | Â | 0.548 |
 Male | 37 | 159 | 37 | 40 | ||
 Female | 20 | 62 | 20 | 17 | ||
Age (yr) | Â | Â | 0.002 | Â | Â | 0.700 |
 < 65 | 23 | 46 | 23 | 21 | ||
 ≥ 65 | 34 | 175 | 34 | 36 | ||
LVEF (%) | 61.00 [60.00,62.00] | 61.00 [60.00,63.00] | 0.570 | 60.95 [59.50,62.50] | 60.74[59.24,62.95] | 0.889 |
BMI (kg/m2) | 23.94 (± 3.28) | 23.61 (± 3.05) | 0.473 | 23.94 (± 3.28) | 23.84 (± 2.85) | 0.850 |
FEV1/FVC | 82.16 [76.57,87.35] | 78.80 [74.09,84.46] | 0.054 | 82.16 [76.58,87.32] | 81.63[76.32,87.11] | 0.923 |
ASA classification (n) | Â | 0.878 | Â | Â | 1.000 | |
 I | 22 | 81 | 22 | 21 | ||
 II | 35 | 140 | 35 | 36 | ||
Smoking (n) | 19 | 87 | 0.403 | 19 | 22 | 0.558 |
Level of tumor (n) | Â | 0.097 | Â | Â | 0.971 | |
 Upper 1/3 | 1 | 16 | 1 | 1 | ||
 Middle 1/3 | 46 | 152 | 46 | 45 | ||
 Lower 1/3 | 10 | 53 | 10 | 11 | ||
Hypertension (n) | 17 | 78 | 0.438 | 17 | 18 | 1.000 |
Diabetes (n) | 5 | 15 | 0.818 | 5 | 6 | 0.751 |
Neoadjuvant (n) | 5 | 20 | 0.948 | 5 | 4 | 0.728 |
Surgery approaches (n) | Â | 0.060 | Â | Â | 1.000 | |
 MIE/Mckenown | 13 | 80 | 13 | 13 | ||
 OE/Ivor Lewis | 44 | 141 | 44 | 44 | ||
Blood loss (ml) | 200.00 [100.00,225.00] | 200.00 [100.00,200.00] | 0.012 | 194.44 [135.94,247.22] | 179.17[115.48,238.54] | 0.447 |
Length of operation (min) | 225.00 [205.00,250.00] | 215.00 [190.00,247.50] | 0.116 | 226.00 [205.25,248.50] | 228.33[197.50,266.25] | 0.557 |
c TNM (n) | Â | Â | 0.351 | Â | Â | 0.888 |
 0 | 5 | 18 | 5 | 6 | ||
 I | 11 | 57 | 11 | 10 | ||
 II | 26 | 110 | 26 | 29 | ||
 III | 15 | 36 | 15 | 15 |